A Retrospective Evaluation of Ocrelizumab and Rituximab Discontinuation in a Canadian Relapsing Multiple Sclerosis Cohort (P7-1.005)

To determine the discontinuation rates of rituximab (RTX) and ocrelizumab (OCR), and reasons for discontinuation in relapsing multiple sclerosis (RMS) patients.

Authors

Karen W. West
Donna kuipers
Nathan Chu (ORCID: https://orcid.org/0000-0001-8721-1174)
Christopher Uy (ORCID: https://orcid.org/0000-0002-0688-6522)
David W. C. Hunt (ORCID: https://orcid.org/0000-0001-9674-3543)
Alice Schabas (ORCID: https://orcid.org/0000-0002-5925-1715)
Virginia Devonshire (ORCID: https://orcid.org/0000-0002-8512-7590)
Ana‐Luiza Sayao

Institutions

University of British Columbia (CA)

Publication Details

Journal: Neurology
Published: 2025-04-07
DOI: https://doi.org/10.1212/wnl.0000000000212542
Primary Topic: Multiple Sclerosis Research Studies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A Retrospective Evaluation of Ocrelizumab and Rituximab Discontinuation in a Canadian Relapsing Multiple Sclerosis Cohort (P7-1.005)

Karen W. West, Donna kuipers, Nathan Chu, Christopher Uy et al.

Apr 7, 2025

1 links

Neurology

Multiple Sclerosis Research Studies

article

A Retrospective Evaluation of Ocrelizumab and Rituximab Discontinuation in a Canadian Relapsing Multiple Sclerosis Cohort (P7-1.005)

Karen W. West, Donna kuipers, Nathan Chu, Christopher Uy, David W. C. Hunt, Alice Schabas, Virginia Devonshire, Ana‐Luiza Sayao

April 7, 2025article en

Abstract

To determine the discontinuation rates of rituximab (RTX) and ocrelizumab (OCR), and reasons for discontinuation in relapsing multiple sclerosis (RMS) patients.

NeurologyVol. 104(7_Supplement_1)

University of British Columbia (CA)

Zero hunger

Openalex Percentile: Top 90%

Multiple Sclerosis Research Studies

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Retrospective Evaluation of Ocrelizumab and Rituximab Discontinuation in a Canadian Relapsing Multiple Sclerosis Cohort (P7-1.005) — Karen W. West, Donna kuipers, et al. · Neurology (2025) | TGRS Research Map | TGRS